Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Ulcerative Colitis Patients

NCT00421642 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00421642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Ulcerative Colitis Patients
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2006
Completion date
April 30, 2008
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis